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Abstract
Background: Although Henoch-Schonlein purpura (HSP) is the most common form of systemic vasculitis in children,
the long term effect of HSP on endothelial function is still not clear. The aim of our study was to evaluate the long
term effect of HSP on endothelial function in children and adolescents.
Methods: This research was an observational prospective study. The study group comprised of 19 children diagnosed
with HSP. The minimum interval between the diagnosis with HSP and endothelial testing was 5 months.
Endothelial function evaluation was assessed by a noninvasive technology named peripheral arterial tonometry, using
an EndoPAT™ device. This method measures blood flow in the limb, in response to arterial occlusion, and calculates a
Reactive Hyperemic Index (RHI) as an index of endothelial function. RHI values of the study group were compared to
those of a known control group.
Results: Nineteen children and adolescents with HSP underwent endothelial function studies. Endothelial function was
compared to that of a known control group comprising of 23 healthy children and adolescents. The two groups had
similar characteristics, including age, male to female ratio, height, weight and BMI.
Mean RHI was 1.81 in the study group, and 1.87 in the control group (p = 0.18). Linear regression of the study group,
showed a positive correlation between the time interval from HSP diagnosis to participation in the study, and between
the RHI value (r = 0.542, p = 0.016). RHI levels were significantly higher in patients who had endothelial function measured
more than 6 years since the diagnosis of HSP compared with those patients with less than 6 years follow up (1.98 + 0.74
vs. 1.38 ± 0.43 P = 0.037).
Conclusions: These results suggest that HSP causes short term endothelial dysfunction that improves with time.
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Background
Henoch-Schonlein purpura (HSP) is the most common
form of systemic vasculitis in children and involves in-
flammation of the small vessels of the skin, joints, gut,
and kidney [1]. Although the precise etiology remains
unclear, it has been reported that vascular endothelial
function plays a major role in the pathogenesis of HSP.
Recent in vitro studies have demonstrated that
markers of endothelial cell damage were elevated in the
acute phase of HSP [2, 3]. However, there have been
only few clinical studies of assessing the long term dam-
age of vascular endothelium in HSP [4].
The earliest stage of atherosclerosis is based on
endothelial dysfunction (ED) [5, 6], since a well func-
tioning endothelium protects the blood vessels from
damage by oxidative stress, by release of anti-
coagulant, anti-inflammatory, fibrinolytic and vasodi-
lating agents [5]. ED can be basically defined as an
impairment of vasodilatation in response to acetylcho-
line or hyperemia, both of which induce nitric oxide-
dependent vasodilatation.
There are several methods to measure endothelial
function. In the present study we used Peripheral Arterial
Tonometry (PAT), a noninvasive technique that analyzes
endothelial function by the measurement of vasodilatation
in response to reactive hyperemia [7].
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The aim of our study was to assess endothelial
function in children with a previous history of




The study includes 19 patients with a previous history
of HSP that were previously hospitalized in the
pediatric department at Meyer Children’s Hospital,
Rambam Medical Center in Israel and were followed
in the pediatric rheumatology clinic. Their diagnosis
was based on the clinical criteria for HSP [8]. The
minimal interval between the diagnosis of HSP and
endothelial study was 5 months. Patients with chronic
renal disease secondary to HSP or other chronic
disease were excluded from the study.
The control group consisted of 23 healthy children
with no evidence of structural or functional heart
disease, and no medical history of Kawasaki disease or
other chronic disorders.
Written informed consent was obtained from all par-
ticipants and/or their parents. The study was approved
by the Rambam Institutional Review Board number
0335-11-RMB.
All subjects were studied in a quiet, temperature-
controlled room. All analyses were performed by a single
experienced operator.
Anthropometric and physical data for each participant
were obtained from the medical charts or were recorded
by the investigators during the test (height, weight,
blood pressure).
Assessment of endothelial function
Endothelial dysfunction evaluation was assessed utilizing
the EndoPAT device (Itamar Medical Ltd, Caesarea,
Israel). This is a noninvasive technology that captures a
beat-to-beat plethysmographic recordings of the finger
arterial pulse-wave amplitude (PWA) with pneumatic
probes. It has been extensively used in our lab both in
adults and in children [7, 9–12].
A finger probe is placed on the index finger of each
hand, and the peripheral arterial tone (PAT) is recorded
from both hands throughout the study. Endothelial func-
tion is assessed using the reactive hyperemia technique.
Briefly, measurements of the pulse-wave amplitude were
obtained during 5 min as baseline (at rest), followed by
5 min of blood flow occlusion in one arm by a cuff that
was inflated on the upper arm to suprasystolic pressure
(50 mmHg above systolic pressure) and then released to
induce reactive (flow-mediated) hyperemia, for 10 min.
The other arm remained un-occluded as a reference to
correct for potential systemic vasomotor changes.
Endothelial function is calculated as the ratio between
the magnitude of the average post-obstructive PWA
(1.5–2.5 min after release of the arterial occlusion) and
average 5 min of baseline PWA (pre-occlusion baseline
period), corrected to systemic changes (observed at the
non-obstructed arm). The threshold for a good EndoPAT
result is an RHI of 1.67 and above (Fig 1).
The test was performed in children aged 7 years and
above, lying on a comfortable examination table in a
cool and quiet room, in the morning or mid- day hours
(8:00–14:00).
Statistical analysis
Statistical analysis included comparisons of PAT values
for endothelial function from the study group and the
control group, as well as comparisons of clinical data
between patients with normal or impaired endothelial
function within the study group.
The results are expressed as average ± standard devi-
ation. Pearson correlation was used for the relation
between age and RHI levels.
We used the two-tailed t-test when normal distribu-
tion was assumed. P < 0.05 considered as statistically
significant.
Linear regression, using standard regression diagnos-
tics was used to look at predictive relationships between
continuous variables. All analyses were performed using
the SPSS version 18, Inc. Chicago, IL, USA.
Results
The study group comprised of 19 children and ado-
lescents that were diagnosed with HSP. Endothelial
function was compared to that of a known control
group of 23 healthy children and adolescents matched
controls. Among the control group, there was no dif-
ferences in RHI values between male and female
(1.85 ± 0.35 vs 1.8 ± 0.3 respectively p = 0.2) as well as
between age and RHI levels in the control group
(R-0.29 P = 0.18).
The average age in the HSP group was 13.5 ± 3.9 years
(range 7–19.7 years) and was similar to the control
group 12.8 ± 4.5 years (range 6–23 years) (p = 0.4), there
were 11/19 male (57%) in the HSP group and 16/23
(69%) male in the control group (P = 0.35). BMI was
similar in both groups, 22 ± 6.1 in the HSP group and
18.8 ± 3.8 in the control group p = 0.13.
Among the children diagnosed with HSP 19 patients
(100%) had rash, 17 (89%) had arthritis, 9 (47%) had ab-
dominal pain, and 7 (37%) had hematuria that resolved
with time.
Six children (31.6%) were treated with steroids during
their hospitalization five of the six patients received ste-
roids for abdominal pain, and for one patient the reason
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was not specified in the medical record. The average
hospitalization were 3.6 ± 2 days (median −3 days).
The average time from the diagnosis of HSP to endo-
thelial function evaluation was 6 ± 3.5 years (median-
6 years). The average RHI value in the patients with
HSP was similar to the control group (1.8 ± 0.7 vs 1.87 ±
0.35 p = 0.18). Twelve of 19 (63%) of the children with
HSP had abnormal RHI compared with 7/23 (30%) in
the control group (p = 0.06).
Correlation between RHI levels and different variables
were assessed. No correlation was found between RHI
and gender (p = 0.27), ethnicity (p = 0.48), BMI (p = 0.84)
and clinical features such as abdominal pain (p = 0.62),
renal involvement (p = 0.58) and length of stay in the
hospital (p = 0.4).
RHI levels among six patients treated with corticoste-
roids was found to be lower than the group without ste-
roids therapy at the time of the diagnosis of HSP (1.35 ±
0.6 vs 1.9 ± 0.6) (p = 0.049).
The average time from diagnosis of HSP to time of
endothelial assessment (TOA) was with high correlation
to RHI (r = 0.542, p = 0.016) (Fig. 1).
Patients with TOA longer than 6 years had significantly
higher RHI levels compared to those with a period shorter
than 6 years (2.2 ± 0.75 vs. 1.38 ± 0.43 p = 0.035) (Fig. 2).
In multivariant regression model to predict RHI level
by different variables (age, gender, TOA, origin, and ster-
oid therapy), the variable were chosen based on correl-
ation between TOA and gender in the univariable
analysis combined with basic demographic data. The
final model included gender (female higher) (β = 0.58
P = 0.034), and the TOA that had a positive effect on
RHI (β = 0.091, P = 0.025).
RHI ¼ 2:112 þ 0:091 TOAþ 0:584 female:
The correlation between TOA and RHI in female was
found to be higher than in male although the RHI
levels were not different (female r = 0.87 p = 0.004 vs
male r = 0.37 p = 0.26).
When other clinical factors were compared between
male and female no differences could be found (Table 1).
Discussion
The vascular endothelium is not only a semi-permeable
barrier between the blood and the interstitium but also a
homeostatic organ with physiological, biological, and
endocrine functions. In adults, several studies have in-
vestigated the peripheral circulation using the forearm
hyperemic response in patient with risk factors for
Fig. 1 Correlation between TOA* to RHI
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atherosclerosis [13–16]. These studies have demon-
strated that peripheral vascular endothelial function
plays a crucial role in preventing the progression to cor-
onary arteriosclerosis. However, in children, there have
been only a few clinical reports of endothelial dysfunc-
tion following vasculitis such as Kawasaki disease as well
as following other inflammatory disease such as SLE and
JIA [17, 18].
In the present study, we demonstrated the attenuated
flow-mediated responses (endothelium-dependent vaso-
relaxation) in the recovery and long term phase of chil-
dren with HSP.
HSP is an inflammatory disease that affect the small
vessels, but unlike other inflammatory diseases such
as SLE and RA, the disease is usually of brief dur-
ation and in most of the cases leaves no damage in
the target organs [1].
A previous study demonstrated endothelial damage in
the acute and subacute phase of patients with HSP [4].
Our study is the first to evaluate the long term effect of
HSP on endothelial function.
There are few methods to evaluate endothelial func-
tion. Quantitive coronary angiography is the most accur-
ate method. In this method during angiography the
coronary response to acetylcholine injection is evaluated
[19]. However this is an invasive method and not suit-
able for children. A second alternative, brachial artery
ultrasound scanning, is a noninvasive method using
Doppler to measure the brachial artery diameter before
and after manometric cuff was inflated to supra-systolic
pressure [6, 20].
In this study, as in previous studies, we used the
Peripheral Arterial Tonography –PAT, a non invasive
technology that captures a beat-to-beat plethysmo-
graphic recordings of the finger arterial pulse-wave amp-
litude (PWA) with pneumatic probes before and after
blood flow occlusion. In adults it has been demonstrated
that endothelial function as measured by the PAT is
highly correlated with the brachial artery ultrasound
measurements [21].
This methods was previously used is several studies
among children [21–24] and based on those studies nor-
mal RHI levels was set to be ≥1.67.
RHI levels in patients with a history of HSP were simi-
lar to the control group. This finding fits with the
known history of patients with HSP who usually develop
no long-term damage in the affected organs. We demon-
strate that more than half of patients with HSP had
abnormal endothelial dysfunction compared to only 30%
in the control group although this differences didn’t
reach significance (p = 0.06). Our results suggest that
endothelial damage may take a long time to recover pos-
sibly years. The only clinical feature that correlated with
decreased RHI was corticosteroid therapy, which may
Table 1 Comparison of different clinical features between genders
Male Female p
TOA 6.2 ± 3.7 (6.6) 5.8 ± 3.6 (5.2) P = 0.90
Age at diagnosis of HSP 7.03 ± 2.40 (7.1) 8.08 ± 3.00 (7.2) P = 0.66
Age of endothelial
assessment
13.24 ± 3.7 (13.3) 13.9 ± 4.5 (14.2) P = 0.78
Abdominal pain 5 (45.5%) 4 (50%) P = 1.00
Arthritis 9 (82%) 8 (100%) P = 0.49
Renal involvement 6 (54.5%) 1 (12.5%) P = 0.15
Steroids treatment 3 (30%) 3 (37.5%) P = 1.00
Fig. 2 RHI levels among patients with *TOA longer and shorter than 6 years
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suggest that patients with severe HSP may have greater
endothelial damage. Several in vitro studies [25–27]
demonstrated that circulating serum growth factor,
adhesion molecules, or other markers of endothelial cell
damage were elevated in the acute phase of HSP, espe-
cially in severe forms developing IgA nephritis. These
vascular abnormalities reduce the availability of nitric
oxide, which induces structural and mechanical changes,
and may offer important insights into the development
and progression of vasculitis initiated end-organ damage.
The present study did not include patients with renal
impairment, since we wanted to rule out other factors
that may affect the endothelial function. Further study is
needed to clarify differences between patients with and
without renal impairment.
Considering that endothelial dysfunction can be the
initial feature of atherosclerosis, and considering that
atherosclerosis is a progressive process that can be
delayed, halted or even be induced to regress [28], other
studies on the effect of HSP on atherosclerosis may be
needed.
The main limitation of our study is the small number
of patients studied. This may explain why we couldn’t
demonstrate RHI differences between the patients with
HSP and the control group.
Another limitation is the population studied as we
evaluate only patients that were hospitalized due to
HSP. Those are usually patients with a more severe HSP
course in which there may have been greater damage to
their endothelium.
The last limitation could be regarding the RHI levels
at different ages. This can effect RHI data when compar-
ing patients with more than 6 years since the diagnosis
of HSP compared with those with less than 6 years.
There is limited data on the influence of age on RHI and
in the control group and so we couldn’t defined any dif-
ferences in RHI levels related to age.
Conclusion
Our study was the first to demonstrate that HSP may
have long term effect on endothelial function. These
changes improve gradually and are not permanent. Fur-
ther larger studies may be needed to assess the effect of
HSP on early development of atherosclerosis.
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